首页> 美国卫生研究院文献>Springer Open Choice >Prognostic value of galectin-3 a novel marker of fibrosis in patients with chronic heart failure: data from the DEAL-HF study

【2h】

Prognostic value of galectin-3 a novel marker of fibrosis in patients with chronic heart failure: data from the DEAL-HF study

机译：Galectin-3（一种纤维化的新标志物）对慢性心力衰竭患者的预后价值：来自DEAL-HF研究的数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsBiomarkers are increasingly being used in the management of patients with chronic heart failure (HF). Galectin-3 is a recently developed biomarker associated with fibrosis and inflammation, and it may play a role in cardiac remodeling in HF. We determined its prognostic value in patients with chronic HF.

机译：AimsBiomarker越来越多地用于治疗慢性心力衰竭（HF）的患者。 Galectin-3是最近开发的与纤维化和炎症相关的生物标志物，它可能在HF的心脏重塑中发挥作用。我们确定了其在慢性心力衰竭患者中的预后价值。

著录项

期刊名称 Springer Open Choice
作者
Dirk J. A. Lok; Peter Van Der Meer; Pieta W. Bruggink-André de la Porte; Erik Lipsic; Jan Van Wijngaarden; Hans L. Hillege; Dirk J. van Veldhuisen;
展开▼
作者单位

展开▼
年(卷),期 -1(99),5
年度 -1
页码 323–328
总页数 6
原文格式 PDF
正文语种
中图分类外科学 ;
关键词
Galectin-3 Chronic heart failure Biomarkers Prognosis;

机译：Galectin-3;慢性心力衰竭;生物标志物;预后;

相似文献

外文文献
中文文献
专利

1. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study [J] . Dirk J. A. Lok, Peter Van Der Meer, Pieta W. Bruggink-André de la Porte, Clinical Research in Cardiology . 2010 ,第5期

机译：Galectin-3（一种纤维化的新标志物）对慢性心力衰竭患者的预后价值：来自DEAL-HF研究的数据
2. “Utility of Plasma Galectin-3, a Novel Marker of Fibrosis, for Evaluation of Syrian Patients with chronic Heart Failure” by MounaKhaity, Faizeh Al-Quobaili, Syria. 52 “HPTLC Method Development and Validation of Indapamide in Bulk Drugs and Formulation Form” [J] . Saraswathi Jaggali, Roja Rani Anupalli, India. International Journal of Pharmaceutical Sciences Review and Research . 2013 ,第2期

机译：叙利亚Faizeh Al-Quobaili的MounaKhaity撰写的“血浆Galectin-3，一种新型的纤维化标记物，用于评估叙利亚慢性心力衰竭患者的实用性”。 52“ HPTLC方法开发和原料药中吲达帕胺的验证和剂型”
3. Utility of Plasma Galectin-3, a Novel Marker of Fibrosis, for Evaluation of Syrian Patients with chronic Heart Failure” [J] . MounaKhaity, Faizeh Al-Quobaili International Journal of Pharmaceutical Sciences Review and Research . 2013 ,第2期

机译：Plasma Galectin-3（一种新型的纤维化标记物）在叙利亚慢性心力衰竭患者评估中的应用”
4. Prognostic value of non invasive baroreflex sensitivity in chronic heart failure patients [C] . Maestri, R., Pinna, . 2001

机译：无创压力反射敏感性在慢性心力衰竭患者中的预后价值
5. Development and Application of Gadolinium Free Cardiac Magnetic Resonance Fibrosis Imaging for Multiscale Study of Heart Failure in Patients with End Stage Renal Disease. [D] . Stromp, Tori A. 2016

机译：用于终末期肾脏疾病患者心衰多尺度研究的无Ga心脏磁共振纤维化成像技术的开发和应用。
6. Comparison the Prognostic Value of Galectin-3 and Serum Markers of Cardiac Extracellular Matrix Turnover in Patients with Chronic Systolic Heart Failure [O] . Yi-Yao Chang, Aaron Chen, Xue-Ming Wu, 2014

机译：比较Galectin-3和血清标志物对慢性收缩性心力衰竭患者的预后价值
7. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure:data from the DEAL-HF study [O] . Lok, Dirk J. A., Van Der Meer, Peter, Bruggink-Andre de la Porte, Pieta W., 2010

机译：Galectin-3（一种纤维化的新标志物）对慢性心力衰竭患者的预后价值：来自DEAL-HF研究的数据

Prognostic value of galectin-3 a novel marker of fibrosis in patients with chronic heart failure: data from the DEAL-HF study

摘要

著录项

相似文献

相关主题

期刊订阅